The recent ITV News investigation, Britain’s Silent Scandal, has laid bare one of the most heartbreaking and neglected public health crises in UK history—the widespread prescription of the pregnancy drug Diethylstilbestrol (DES), and the lifelong consequences it has inflicted on generations of women and their families.
Led by Social Affairs Correspondent Sarah Corker, the investigation shines a light on a silent tragedy spanning more than four decades. DES, once hailed as a miracle drug to prevent miscarriages and suppress breast milk, was routinely prescribed to pregnant women in the UK from the 1940s until well into the 1970s. Despite mounting evidence linking DES to cancer and reproductive harm, many women were still given the drug as late as 1979, years after official guidance urged its withdrawal in 1971.
An estimated 300,000 women in the UK were exposed to DES, either directly or through their mothers. The result has been devastating: rare reproductive cancers, infertility, anatomical abnormalities, chronic pain, and an ongoing psychological toll. Even more disturbing, medical research confirms that the effects of DES can be passed down through generations, impacting not only the women who were prescribed the drug, but their daughters, sons, and even grandchildren.
One such woman is Suzanne Massey, 56, from Liverpool. Exposed to DES in utero, Ms. Massey has endured more than 30 invasive surgeries and procedures throughout her life. Her reproductive system, she says, was found to be “covered in rare, abnormal cells,” which ultimately led to a hysterectomy. Speaking to ITV News, she described the trauma: “It’s a pain that no woman should have to go through. It’s been barbaric at times.” She adds, “I’ve been in hospital for procedures or operations every year for the last 25 years. I want awareness, screening and compensation, because it’s taken some of my life away, and I can’t get that back.”
Her story is one of many. ITV News heard from over 100 women who believe they were harmed by DES. Many have been diagnosed with rare cancers. Others describe lifelong battles with infertility, miscarriages, and unexplained gynaecological issues.
DES daughters like Ms. Massey have found little recourse in the UK. Despite successful lawsuits in the United States, France and the Netherlands, there have been no successful legal claims in this country. Poor NHS record keeping, lack of public awareness, and a disjointed response from health authorities have created a nearly impenetrable wall of denial and inaction. As Clare Fletcher, Ms. Massey’s solicitor at Broudie Jackson Canter, put it: “These are lifelong injuries from this horrendous drug. It’s time for accountability. The government must accept what they knew about this drug and when.”
What makes the silence around DES so alarming is that it was never truly hidden. As early as the 1950s, safety concerns were being raised. In 1971, researchers definitively linked DES exposure in utero to a rare vaginal cancer. This led to official guidance from the Committee on Safety of Medicines in 1973, advising doctors to stop prescribing DES to pregnant women. Yet ITV uncovered evidence that women continued to receive it through the late 1970s, due to inconsistencies in communication, record-keeping, and oversight.
Even now, doctors and patients are left in the dark. DES exposure remains poorly understood in the UK medical community, and many women may still not know they were given the drug or passed its effects to their children. Dr. Ahmed Talaat, Consultant Gynaecologist at University Hospitals Plymouth, has treated more than a dozen DES daughters. “The risk of cancer including cancer of vagina, or the cervix is nearly doubled in patients whose mothers received DES. That’s why they should be under close observation with regular screening,” he explained.
This is not merely a story about a drug with unintended side effects. It is a case of systemic failure—of women not being heard, of science being ignored, and of institutions failing to act despite overwhelming evidence. It is time for the UK government to right this historical wrong.
Urgent action is needed. This must start with a nationwide investigation to determine the full scale of DES exposure, and an immediate rollout of enhanced cancer screening for known and suspected victims. The Department of Health and Social Care must go beyond vague expressions of sympathy and establish a formal compensation scheme for affected families. We also support the calls for legal accountability and demand full transparency around what the government and medical regulators knew—and when.
Three generations of the Hall family, featured in ITV’s report, believe their health problems stem from DES. This intergenerational harm must not be ignored any longer. These women—and their children and grandchildren—deserve justice, care, and recognition.
We applaud the brave women who have come forward to share their stories. We echo their calls for awareness, health screening, legal redress, and justice.
